AnalystsJames MainwaringJames Mainwaring's Stock Forecasts
AnalystsJames Mainwaring
Sectors:
Industries:
Analyst Ranking
Bottom 41%
#2895 out of 4871 analysts
Average Return
+0.12%
Win Rate
50%1 out of 2
Risk vs Reward
Poor
Good
James Mainwaring's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dexcom IncDXCM | +23.18% | $99.87 | $123.03 | 2021-04-15 - 2022-04-14 | Strong Buy |
James Mainwaring Analyst Color
Get additional color on James Mainwaring's coverage of popular stocks
James Mainwaring's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Medtronic PLCMDT | 1 | Hold | $105.00 | N/A | Downgrades | 3 years ago |
Abbott LaboratoriesABT | 1 | Strong Buy | $144.00 | N/A | Upgrades | 4 years ago |
Edwards Lifesciences CorpEW | 1 | Hold | $85.00 | N/A | Initiates Coverage On | 4 years ago |
Dexcom IncDXCM | 1 | Strong Buy | $109.50 | N/A | Initiates Coverage On | 4 years ago |
Illumina IncILMN | 1 | Hold | $390.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.